HU181926B - Process for the isolation of precipitated proteins from suspensions containing albumin - Google Patents
Process for the isolation of precipitated proteins from suspensions containing albumin Download PDFInfo
- Publication number
- HU181926B HU181926B HU76PA1271A HUPA001271A HU181926B HU 181926 B HU181926 B HU 181926B HU 76PA1271 A HU76PA1271 A HU 76PA1271A HU PA001271 A HUPA001271 A HU PA001271A HU 181926 B HU181926 B HU 181926B
- Authority
- HU
- Hungary
- Prior art keywords
- filter
- albumin
- filtration
- suspension
- solution
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 58
- 108010088751 Albumins Proteins 0.000 title claims abstract description 44
- 102000009027 Albumins Human genes 0.000 title claims abstract description 44
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 22
- 239000000725 suspension Substances 0.000 title claims abstract description 17
- 238000002955 isolation Methods 0.000 title description 3
- 238000001914 filtration Methods 0.000 claims abstract description 40
- 239000000706 filtrate Substances 0.000 claims abstract description 15
- 239000004744 fabric Substances 0.000 claims abstract description 7
- 239000002002 slurry Substances 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 5
- 102000004506 Blood Proteins Human genes 0.000 claims description 4
- 108010017384 Blood Proteins Proteins 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 210000002381 plasma Anatomy 0.000 abstract description 14
- 238000000926 separation method Methods 0.000 abstract description 9
- 239000000470 constituent Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 239000000839 emulsion Substances 0.000 abstract 1
- 238000005188 flotation Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 21
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 238000005119 centrifugation Methods 0.000 description 11
- 108010044091 Globulins Proteins 0.000 description 10
- 102000006395 Globulins Human genes 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000000665 Cohn process Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 108010074605 gamma-Globulins Proteins 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 108010049003 Fibrinogen Proteins 0.000 description 4
- 102000008946 Fibrinogen Human genes 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 229940012952 fibrinogen Drugs 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 3
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003114 blood coagulation factor Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 229960005480 sodium caprylate Drugs 0.000 description 3
- BYKRNSHANADUFY-UHFFFAOYSA-M sodium octanoate Chemical compound [Na+].CCCCCCCC([O-])=O BYKRNSHANADUFY-UHFFFAOYSA-M 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000010802 sludge Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 102000002572 Alpha-Globulins Human genes 0.000 description 1
- 108010068307 Alpha-Globulins Proteins 0.000 description 1
- 102000006734 Beta-Globulins Human genes 0.000 description 1
- 108010087504 Beta-Globulins Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 210000003918 fraction a Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000000521 hyperimmunizing effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical class CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2556733A DE2556733C3 (de) | 1975-12-17 | 1975-12-17 | Verfahren zum Isolieren von Albumin aus Blutplasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU181926B true HU181926B (en) | 1983-11-28 |
Family
ID=5964580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU76PA1271A HU181926B (en) | 1975-12-17 | 1976-12-16 | Process for the isolation of precipitated proteins from suspensions containing albumin |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS6033089B2 (ref) |
| AT (1) | AT346491B (ref) |
| AU (1) | AU508955B2 (ref) |
| BE (1) | BE849464R (ref) |
| CA (1) | CA1079269A (ref) |
| CH (1) | CH632277A5 (ref) |
| DD (1) | DD128726A6 (ref) |
| DE (1) | DE2556733C3 (ref) |
| DK (1) | DK149135C (ref) |
| EG (1) | EG12610A (ref) |
| ES (1) | ES454379A2 (ref) |
| FI (1) | FI56844C (ref) |
| FR (1) | FR2335521A2 (ref) |
| GB (1) | GB1569168A (ref) |
| HU (1) | HU181926B (ref) |
| IE (1) | IE44048B1 (ref) |
| IL (1) | IL51110A (ref) |
| MX (1) | MX3915E (ref) |
| NL (1) | NL7613906A (ref) |
| PL (1) | PL106430B3 (ref) |
| SE (1) | SE445517B (ref) |
| ZA (1) | ZA767503B (ref) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4483807A (en) * | 1981-01-27 | 1984-11-20 | Japan Atomic Energy Research Institute | Process for producing a slow release composite |
| DE3307871C2 (de) * | 1983-03-05 | 1986-10-30 | R & Z Biologicals S.A. (Pty.) Ltd., Cape Town | Verfahren zur Gewinnung von hochreinem Albumin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2705230A (en) * | 1949-09-23 | 1955-03-29 | Allen F Reid | Method of purifying albumin |
| US2765299A (en) * | 1952-06-27 | 1956-10-02 | Armour & Co | Recovery of serum albumin |
| FR2247471A1 (en) * | 1973-10-15 | 1975-05-09 | Ts Institu | Pure serum albumin isolated from biological liquids - by treatment with alcohol and aliphatic carboxylic acid salt |
| DE2415079C3 (de) * | 1974-03-28 | 1980-02-14 | Plasmesco Ag, Zug (Schweiz) | Verfahren zum Isolieren von Albumin aus Blutplasma |
-
1975
- 1975-12-17 DE DE2556733A patent/DE2556733C3/de not_active Expired
-
1976
- 1976-12-10 IE IE2712/76A patent/IE44048B1/en unknown
- 1976-12-13 SE SE7613968A patent/SE445517B/xx unknown
- 1976-12-14 DK DK559876A patent/DK149135C/da not_active IP Right Cessation
- 1976-12-15 FI FI763610A patent/FI56844C/fi not_active IP Right Cessation
- 1976-12-15 DD DD7600196377A patent/DD128726A6/xx unknown
- 1976-12-15 GB GB52438/76A patent/GB1569168A/en not_active Expired
- 1976-12-15 NL NL7613906A patent/NL7613906A/xx not_active Application Discontinuation
- 1976-12-15 EG EG769/76A patent/EG12610A/xx active
- 1976-12-15 IL IL51110A patent/IL51110A/xx unknown
- 1976-12-16 AU AU20599/76A patent/AU508955B2/en not_active Expired
- 1976-12-16 HU HU76PA1271A patent/HU181926B/hu unknown
- 1976-12-16 BE BE173309A patent/BE849464R/xx not_active IP Right Cessation
- 1976-12-16 FR FR7637897A patent/FR2335521A2/fr active Granted
- 1976-12-16 PL PL1976194451A patent/PL106430B3/pl unknown
- 1976-12-16 CA CA268,010A patent/CA1079269A/en not_active Expired
- 1976-12-16 AT AT932976A patent/AT346491B/de not_active IP Right Cessation
- 1976-12-17 JP JP51150986A patent/JPS6033089B2/ja not_active Expired
- 1976-12-17 ES ES454379A patent/ES454379A2/es not_active Expired
- 1976-12-17 CH CH1593176A patent/CH632277A5/de not_active IP Right Cessation
- 1976-12-17 ZA ZA767503A patent/ZA767503B/xx unknown
- 1976-12-17 MX MX76100452U patent/MX3915E/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK559876A (da) | 1977-06-18 |
| EG12610A (en) | 1979-06-30 |
| BE849464R (fr) | 1977-04-15 |
| FR2335521B2 (ref) | 1982-10-29 |
| ATA932976A (de) | 1978-03-15 |
| DE2556733C3 (de) | 1986-10-02 |
| AT346491B (de) | 1978-11-10 |
| DE2556733A1 (de) | 1977-11-17 |
| DD128726A6 (de) | 1977-12-07 |
| IL51110A (en) | 1979-11-30 |
| JPS6033089B2 (ja) | 1985-08-01 |
| IE44048B1 (en) | 1981-07-29 |
| FI763610A7 (ref) | 1977-06-18 |
| NL7613906A (nl) | 1977-06-21 |
| DK149135B (da) | 1986-02-10 |
| FI56844C (fi) | 1980-04-10 |
| FR2335521A2 (fr) | 1977-07-15 |
| DE2556733B2 (de) | 1981-05-14 |
| PL106430B3 (pl) | 1979-12-31 |
| SE7613968L (sv) | 1977-06-18 |
| SE445517B (sv) | 1986-06-30 |
| MX3915E (es) | 1981-09-18 |
| CH632277A5 (en) | 1982-09-30 |
| FI56844B (fi) | 1979-12-31 |
| AU508955B2 (en) | 1980-04-17 |
| IL51110A0 (en) | 1977-02-28 |
| CA1079269A (en) | 1980-06-10 |
| JPS5283926A (en) | 1977-07-13 |
| GB1569168A (en) | 1980-06-11 |
| ES454379A2 (es) | 1978-07-16 |
| DK149135C (da) | 1986-07-14 |
| AU2059976A (en) | 1978-06-22 |
| ZA767503B (en) | 1977-11-30 |
| IE44048L (en) | 1977-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4156681A (en) | Process for isolating albumin from blood | |
| EP0390821B1 (en) | Process for extracting pure fractions of lactoperoxidase and lactoferrin from milk serum | |
| JPS60224626A (ja) | 基質を含まず、肝炎の心配のない、高純度のヒト及び動物ヘモグロビン溶液の製造方法 | |
| JP2001200000A (ja) | 海洋生物由来コラーゲンの製造方法 | |
| US4863609A (en) | Process for the fractional separation of protein mixtures by means of membranes | |
| JP2022120038A (ja) | タンパク質抽出方法およびシステム | |
| JPS60149526A (ja) | 溶血血液の未変性形の主タンパクの調製方法 | |
| CN112480243A (zh) | 一种规模化水蛭素分离纯化生产工艺方法及设备 | |
| JP3577992B2 (ja) | 膜分離方法 | |
| CN109836346B (zh) | 一种异亮氨酸发酵液的提纯工艺 | |
| HU181926B (en) | Process for the isolation of precipitated proteins from suspensions containing albumin | |
| CA1112639A (en) | Mono-insulin and method of preparing the same | |
| JP2003092996A (ja) | イミダゾールジペプチド類含有組成物の製造方法 | |
| WO2022035334A2 (en) | Method of obtaining aprotinin and product obtained thereby | |
| RU2062617C1 (ru) | Способ получения антитоксической сыворотки | |
| JP3371783B2 (ja) | 菌体分離方法 | |
| JPS63145288A (ja) | 改良されたフイチン酸の製造方法 | |
| JPH0114788B2 (ref) | ||
| JPH11215980A (ja) | 菌体含有液の処理方法 | |
| JPS6040831B2 (ja) | 微生物培養液の処理方法 | |
| CN120988053A (zh) | 一种血浆蛋白分离方法 | |
| KR820002225B1 (ko) | 간염 b 표면 항원의 제조방법 | |
| SU902701A1 (ru) | Способ регенерации рассола при посоле м сопродуктов | |
| RU2195316C1 (ru) | Способ получения основного ингибитора протеиназ | |
| KR830002718B1 (ko) | 혈장으로부터 알부민을 분리 제조하는 방법 |